DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/brqk7j/world) has announced the addition of the "World Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics - Market Opportunity and Forecast, 2014 - 2020" report to their offering. The global CRPC market is expected to reach $9.5 billion by 2020, at a CAGR of 9.1% during the forecast period (2015-2020) Promising drug pipeline, evolving treatment patterns, emerging untapped non-metastatic CRPC sp
| < Prev | Next > |
|---|
